CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Rex Medical, L.P., today announced that it has received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration to begin a U.S. clinical trial for the Option™ Retrievable Vena Cava Filter in the prevention of recurrent Pulmonary Embolism (PE).
